Sign up to save your podcasts
Or
Share Beyond APHINITY: What Now After Pivotal Breast Cancer Trial?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Beyond APHINITY: What Now After Pivotal Breast Cancer Trial?
Dr Kathy Miller speaks with APHINITY's principal investigator about whether survival in HER2+ disease can be pushed even further.
View all episodes
By MedscapeDr Kathy Miller speaks with APHINITY's principal investigator about whether survival in HER2+ disease can be pushed even further.